COVID-19, ascertained (n = 9) | |
Age years-old, mean (SD) | 46.22 ± 9.55 |
Range | 35–65 |
Gender (Female), n (%) | 3 (33.3) |
Clinical symptomatology, COVID-19 | |
Fever, n (%) | 7/9 (77.8) |
Coughing, n (%) | 4/9 (44.4) |
Headache, n (%) | 2/9 (22.2) |
Dyspnea, n (%) | 4/9 (44.4) |
Muscular Pain, n (%) | 3/9 (33.3) |
Sense of Tiredness/Fatigue, n (%) | 5/9 (55.5) |
Diarrhoea, n (%) | 2/9 (22.2) |
Sore Throat, n (%) | 2/9 (22.2) |
Rhinorrhea, n (%) | 0/9 |
Conjunctivitis, n (%) | 0/9 |
Gustative/olfactory sensory impairment, n (%) | 3/9 (33.3) |
None (Asymptomatic), n (%) | 1/9 (11.1) |
Clinical management and outcomes, COVID-19 | |
Rx-confirmed Pneumoniaa, n (%) | 4/9 (44.4) |
Domiciliar management, n (%) | 7/9 (77.8) |
Oxygen support therapy at domiciliar regimen, n (%) | 0/9 |
Hospitalization required, n (%) | 2/9 (22.2) |
Non-invasive ventilation, n (%) | 1/9 (11.1) |
Invasive ventilation (intubation), n (%) | 1/9 (11.1) |
Death, n (%) | 0/9 |